Toloria S. DuVall

Toloria S. DuVall serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from market research and solicitation development to contract award and administration. She plays a pivotal role in advancing her agency’s mission by ensuring compliance with federal procurement regulations, particularly under the FAR, while promoting efficient and transparent contracting practices. Her portfolio primarily encompasses research and development services, pharmaceutical manufacturing, and biotechnology-related procurements, requiring deep technical understanding and risk mitigation expertise in highly regulated scientific domains. DuVall cultivates collaborative relationships with a diverse range of vendors, including established scientific contractors, specialized manufacturing firms, and small businesses with niche technical capabilities. While no single contractor dominates her award profile, she consistently engages with firms possessing validated expertise in laboratory research, process development, and GMP-compliant production. Her contracting approach emphasizes performance-based outcomes, clear statement of work development, and rigorous source selection criteria to ensure technical excellence and mission alignment. Her procurement strategy reflects a strong preference for open competition, with 90% of acquisitions conducted without set-asides. Nevertheless, she actively supports small business participation through targeted Total Small Business Set-Asides and HUBZone contracts, demonstrating a deliberate commitment to socioeconomic objectives under FAR Part 19. This balanced approach ensures broad market access while fulfilling statutory obligations to promote economic opportunity for disadvantaged communities and qualified small businesses. DuVall’s technical focus centers on NAICS 541715 and 541712, encompassing physical and engineering research services, with additional emphasis on pharmaceutical (325412) and biological product manufacturing (325414), as well as biotechnology research (541714). She routinely procures contract research services, analytical testing, process scale-up, and GMP manufacturing capabilities, requiring familiarity with FDA regulatory frameworks, clinical trial support infrastructure, and laboratory instrumentation standards. Her expertise enables her to effectively evaluate technical proposals and ensure contractor readiness in highly specialized scientific markets.